| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.3 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |